IMC vs SPL

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

IMC

IMMURON FPO [IMC]

49LOW

SPL

STARPHARMA FPO [SPL]

49LOW

Score Breakdown

IMC SPL
Technical
51
48
Catalyst
50
65
Sentiment
50
50
Fundamental
64
72
Momentum
36
82
Risk Gate
45
50

Key Metrics

IMC Metric SPL
$9.5MMarket Cap$195.3M
241KAvg Volume (20d)1.7M
N/AShort Interest+0.1%
$0.09852-Week High$0.525
$0.02752-Week Low$0.082
-3.4%Daily Change+0.0%
$0.028Entry Price$0.465
-39.7%ROE-14.5%
-62.1%Profit Margin-22.2%

Active Signals

IMC Signals

●RSI drifting toward oversold territory — worth watching
●MACD just crossed bullish — momentum is shifting to the upside
●Trading below both moving averages — the trend is working against this one
●Volatility is expanding fast — choppy price action, so buckle up
●Below the 200-day average — the long-term trend is still working against it
●Strong cash runway (9 quarters)
●Low P/S ratio (1.3x)
●Near 52-week low (3% of range)

SPL Signals

●Stochastic is stretched into overbought — could need a breather
●Trading above both moving averages — the trend is your friend here
●Watch out — volume is flowing out even as price holds up. Distribution pattern
●Trading above the 200-day average — the long-term trend is on your side
●Strong cash runway (86 quarters)
●Moderate P/S ratio (13.4x)
●Strong revenue growth (+360%)
●EPS estimates revised downward (-10pts)

Ask Scout AI to compare IMC and SPL in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
IMC Full Analysis → SPL Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).